NCT05843877 2026-01-30
XandTX
Technische Universität Dresden
Phase 3 Recruiting
Clinical Trials
24 trialsNCT06132087 2025-11-25
PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy
University of Southern California
Phase NA Active not recruiting
NCT02517268 2025-04-30
WARP
Thomas Jefferson University
Phase NA Completed
NCT06703905 2024-11-25
Conventional Partial Pancreatoduodenectomy Versus an Extended Pancreatoduodenectomy for Pancreatic Head Cancers
First Affiliated Hospital Xi'an Jiaotong University
Phase NA Not yet recruiting
NCT05462496 2024-10-15
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
Icahn School of Medicine at Mount Sinai
Phase 2 Recruiting
NCT06413888 2024-05-14
whipple
Baylor College of Medicine
Phase NA Completed
NCT02243358 2023-10-27
Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer
Henry Ford Health System
Phase 2 Completed
NCT04007640 2022-07-08
PAIR-PANCREAS
Assistance Publique - Hôpitaux de Paris
Phase NA Unknown
NCT02850874 2022-04-27
HIPEC as Neoadjuvant Treatment for Resectable Pancreatic Adenocarcinoma
Wake Forest University Health Sciences
Phase 2 Withdrawn
NCT02787187 2021-11-23
Lymphadenectomy for Pancreatic Head Cancer: Standard or Extended?
Ruijin Hospital
Phase NA Completed
NCT04823832 2021-04-01
Endoscopic Versus Percutaneous Biliary Drainage for Resectable Pancreatic Head Cancer
Alexandria University
Phase NA Completed
NCT03718650 2021-02-08
Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Withdrawn
NCT04487002 2020-07-27
GIST
Alexandria University
Phase NA Completed
NCT02803814 2020-07-22
DUOPAN-EPAM
Fundación para la Investigación del Hospital ClÃnico de Valencia
Phase NA Completed
NCT01240304 2019-12-10
A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas
University of Arkansas
Phase 2 Terminated
NCT01989000 2018-06-27
MIPA
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase NA Completed
NCT01903083 2018-02-01
CRIT
Providence Health & Services
Phase 1 Completed
NCT03317886 2017-10-24
Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer
Wakayama Medical University
Phase 3 Unknown
NCT02246205 2017-10-16
PAUDA
Hospital Universitari de Bellvitge
Phase NA Completed
NCT00766636 2016-05-19
Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT02081131 2015-09-15
PLOT
GEM Hospital & Research Center
Phase NA Completed
NCT01941342 2014-01-14
Evaluation of Preoperative Biliary Drainage Before Pancreatoduodenectomy
Southwest Hospital, China
Phase 2 Unknown
NCT00761241 2010-05-26
Borderline Resectable Pancreatic Cancer: Gemcitabine/Docetaxel and Oxaliplatin Based Chemo/RT
Benaroya Research Institute
Phase 2 Completed
NCT01059097 2010-01-29
Effect of Surgeon Volume on Outcome of Pancreaticoduodenectomy
Università Vita-Salute San Raffaele
Phase NA Completed